{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:22:45Z","timestamp":1787775765772,"version":"build-2784847793"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is the most frequently diagnosed malignancy in men. It is the commonest cancer in Nigerian men. Multiparametric magnetic resonance imaging (mpMRI) is essential in the evaluation of patients with PCa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To evaluate the clinicopathologic profile and pelvic MRI pattern of prostate cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a retrospective study performed between July 2020 and June 2024. The study population was derived from men with histologically diagnosed PCa who subsequently had mpMRI for cancer staging. From the medical records, age, prebiopsy PSA, Gleason score (GS) and other relevant information were obtained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The records of 458 subjects were retrieved. A total number of 229 subjects had their prebiopsy PSA recorded while 158 subjects had their GS recorded. The mean age of the subjects was 66.38 \u00b1 8.46 years, while the mean and median prebiopsy PSA were 49.37 \u00b1 59.81 ng\/ml and 33ng\/ml, respectively. The mean GS of the subjects was 7.72 \u00b1 1.29. The prostate capsule was the most commonly invaded structure (65.4%). The prevalence of bone metastasis was 22.8%, and the spine was the most commonly affected bone. Stage 3 and stage 4 disease were the most predominantly observed (58.4% and 32%, respectively). There was a statistically significant but weak correlation between tumor stage and GS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The subjects\u2019 clinicopathologic profile and pelvic MRI findings show that patients commonly present with advanced prostate cancer in our environment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_766_24","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T23:00:20Z","timestamp":1745794820000},"page":"508-512","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic Profile and Pelvic Magnetic Resonance Imaging Pattern of Prostate Cancer in Southeast Nigeria"],"prefix":"10.4103","volume":"28","author":[{"given":"SK","family":"Anyimba","sequence":"first","affiliation":[{"name":"Department of Surgery, College of Medicine, Urology Division, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EC","family":"Ajare","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OM","family":"Mbadiwe","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, Urology Division, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EF","family":"Nnakenyi","sequence":"additional","affiliation":[{"name":"Department of Morbid Anatomy, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OC","family":"Amu","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, Urology Division, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AC","family":"Onuh","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AC","family":"Ilo","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EK","family":"Mgbe","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"R1-20260423","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"W715","DOI":"10.2214\/AJR.10.5700","article-title":"Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer","volume":"196","author":"Vilanova","year":"2011","journal-title":"AJR"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"560857","DOI":"10.1155\/2013\/560857","article-title":"Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent","volume":"2013","author":"Rebbeck","year":"2013","journal-title":"Prostate Cancer"},{"key":"R4-20260423","first-page":"159","article-title":"Increased incidence of prostate cancer in Nigerians","volume":"91","author":"Ogunbiyi","year":"1999","journal-title":"J Natl med Assoc"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4314\/njm.v17i3.37396","article-title":"Cancer in Nigeria: A 10 year analysis of the Kano cancer registry","volume":"17","author":"Mohammed","year":"2008","journal-title":"Niger J Med"},{"key":"R6-20260423","first-page":"539","article-title":"Roots of prostate cancer in African-American men","volume":"98","author":"Odedina","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"R7-20260423","first-page":"271","article-title":"Cancer treatment and survivorship statistics","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jama.280.11.975","article-title":"Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer","volume":"280","author":"Albertsen","year":"1998","journal-title":"J Am Med Assoc"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.juro.2009.10.046","article-title":"An update of the Gleason grading system","volume":"183","author":"Epstein","year":"2010","journal-title":"J Urol"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrclinonc.2014.69","article-title":"Multiparametric MRI in prostate cancer management","volume":"11","author":"Johnson","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/iju.13119","article-title":"Multiparametric magnetic resonance imaging: Current role in prostate cancer management","volume":"23","author":"Ueno","year":"2016","journal-title":"Int J Urol"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.rcl.2006.10.008","article-title":"Imaging of prostate cancer","volume":"45","author":"Akin","year":"2007","journal-title":"Radiol Clin North Am"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"296810","DOI":"10.1155\/2014\/296810","article-title":"Multiparametric MRI in prostate cancer","volume":"2014","author":"Esen","year":"2014","journal-title":"Biomed Res Int"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2214\/AJR.09.2527","article-title":"Imaging localized prostate cancer: Current approaches and new developments","volume":"192","author":"Turkbey","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2214\/AJR.11.6861","article-title":"Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: Correlation of quantitative MR parameters with gleason score and tumour angiogenesis","volume":"197","author":"Oto","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)12713-4","article-title":"Prostate cancer epidemiology","volume":"361","author":"Gronberg","year":"2003","journal-title":"Lancet"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"W43","DOI":"10.2214\/AJR.14.12689","article-title":"Periprostatic fat thickness on MRI: Correlation with gleason score in prostate cancer","volume":"204","author":"Woo","year":"2015","journal-title":"AJR"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pros.10239","article-title":"Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy gleason score in clinically localized prostate cancer","volume":"56","author":"Horiguchi","year":"2003","journal-title":"Prostate"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1442-2042.2008.02042.x","article-title":"Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer","volume":"15","author":"Nishimoto","year":"2008","journal-title":"Int J Urol"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/jmri.24813","article-title":"Correlation of gleason scores with magnetic resonance diffusion tensor imaging in peripheral zone prostate cancer","volume":"42","author":"Li","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"650117","DOI":"10.3389\/fonc.2021.650117","article-title":"Cancer in Africa: The untold story","volume":"11","author":"Hamdi","year":"2021","journal-title":"Front Oncol"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/atp.atp_18_20","article-title":"Clinicopathological characteristics of benign prostatic hyperplasia and prostate cancer in a university teaching hospital in Nigeria","volume":"11","author":"Adetola","year":"2020","journal-title":"Ann Trop Pathol"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4103\/0300-1652.170388","article-title":"A histological study of prostate lesions in Lagos, Nigeria: A private practice experience","volume":"56","author":"Nwafor","year":"2015","journal-title":"Niger Med J"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"129","DOI":"10.11604\/pamj.2013.15.129.2489","article-title":"Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination","volume":"15","author":"Ikuerowo","year":"2013","journal-title":"Pan Afr Med J"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4103\/NJM.NJM_10_24","article-title":"Toothache as the leading clinical symptom of metastatic prostate adenocarcinoma","volume":"32","author":"Anyimba","year":"2023","journal-title":"Niger J Med"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1055-9965.EPI-08-0203","article-title":"Explaining the race difference in prostate cancer stage at diagnosis","volume":"17","author":"Jones","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12301-022-00273-y","article-title":"A comparison of clinicopathologic features of prostate cancer between Nigerian and South African black men","volume":"28","author":"Ahmed","year":"2022","journal-title":"Afr J Urol"},{"key":"R29-20260423","first-page":"325","article-title":"Clinicopathologic features and determinants of Gleason score of prostate cancer in Ghanaian men","volume":"31","author":"Yarney","year":"2013","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4236\/oju.2014.41002","article-title":"Prostate cancer disease characteristics at the time of diagnosis and initial treatment offered in a tertiary hospital at Ouagadougou (Burkina Faso)","volume":"4","author":"Kabore","year":"2014","journal-title":"Open J Urol"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1002\/1097-0142(19930415)71:8<2569::AID-CNCR2820710822>3.0.CO;2-R","article-title":"Stage at presentation and survival of white and black patients with prostate carcinoma","volume":"71","author":"Brawn","year":"1993","journal-title":"Cancer"},{"key":"R32-20260423","first-page":"15","article-title":"Prostate cancer in sub Saharan Africa","volume":"1","author":"Jalloh","year":"2013","journal-title":"J Nephrol Urolog Res"},{"key":"R33-20260423","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00000478-199705000-00010","article-title":"Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings","volume":"21","author":"Steinberg","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R34-20260423","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.urology.2006.10.036","article-title":"Upgrading and downgrading of prostate needle biopsy specimens: Risk factors and clinical implications","volume":"69","author":"Freedland","year":"2007","journal-title":"Urology"},{"key":"R35-20260423","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","article-title":"Can clinically significant prostate cancer be detected with multipatametric magnetic resonance imaging? A systematic review of the literature","volume":"68","author":"Ftterer","year":"2015","journal-title":"Eur Urol"},{"key":"R36-20260423","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3348\/kjr.2017.18.4.597","article-title":"Multiparametric MRI in the detection of clinically significant prostate cancer","volume":"18","author":"F\u00fctterer","year":"2017","journal-title":"Korean J Radiol"},{"key":"R37-20260423","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1148\/radiol.2017160906","article-title":"Prostate cancer: A correlative study of multiparametric MR imaging and digital histopathology","volume":"285","author":"Kwak","year":"2017","journal-title":"Radiology"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5489\/cuaj.11085","article-title":"Pre-treatment risk stratification of prostate cancer patients: A critical review","volume":"6","author":"Rodrigues","year":"2012","journal-title":"Can Urol Assoc J"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_766_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:41:38Z","timestamp":1787773298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_766_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_766_24","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-11-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}